Breathonix develops portable breath analyzers for the rapid, non-invasive detection of infectious diseases and cancer, utilizing real-time breath acetone level measurements. This technology addresses the need for faster and less invasive diagnostic methods compared to traditional blood tests, enabling timely health monitoring and emergency diagnosis.
Funding
$160K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional diagnostic methods for infectious diseases and metabolic disorders often rely on invasive procedures like blood draws, which can be time-consuming, uncomfortable for patients, and require specialized personnel. The need for rapid, non-invasive, and point-of-care diagnostic tools is critical for timely intervention and effective disease management.
Solution
Breathonix offers a suite of portable breath analyzers designed for the rapid and non-invasive detection of various conditions, including infectious diseases and metabolic imbalances. Their technology measures real-time breath acetone levels and other volatile organic compounds (VOCs) to provide immediate insights into a patient's health status. The MetaDR device, for example, enables non-invasive home monitoring of diabetes, emergency diagnosis of diabetic ketoacidosis, and non-invasive monitoring of epilepsy. The BreFence Go system facilitates rapid COVID-19 testing.
Target Audience
The primary target audience includes healthcare providers seeking rapid diagnostic tools, individuals with diabetes or epilepsy requiring convenient home monitoring solutions, and organizations needing efficient COVID-19 testing methods.
Features
- Real-time breath analysis for immediate results within seconds
- Non-invasive procedure eliminating the need for blood samples
- Portable, handheld design for point-of-care or at-home use
- Capability to detect various biomarkers, including acetone for metabolic monitoring
- Potential applications in infectious disease detection (e.g., COVID-19) and chronic disease management (e.g., diabetes, epilepsy)
- Optional companion mobile app for data storage and health management
- FDA registered MetaDR device